194 related articles for article (PubMed ID: 26825195)
1. 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
Florimonte L; Orunesu E; Castellani M; Longari V; Cortelezzi A
Clin Nucl Med; 2016 May; 41(5):394-6. PubMed ID: 26825195
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Vadrucci M; Gilardi L; Grana CM
Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
Haroon A; Syed R; Endozo R; Allie R; Freeman A; Emberton M; Bomanji J
Nucl Med Commun; 2017 May; 38(5):407-414. PubMed ID: 28379896
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
Beheshti M; Rezaee A; Geinitz H; Loidl W; Pirich C; Langsteger W
J Nucl Med; 2016 Oct; 57(Suppl 3):55S-60S. PubMed ID: 27694173
[No Abstract] [Full Text] [Related]
5. Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
Alabed YZ
Clin Nucl Med; 2018 Mar; 43(3):220-221. PubMed ID: 29356739
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
Garcia JR; Moreno C; Valls E; Cozar P; Bassa P; Soler M; Alvarez-Moro FJ; Moragas M; Riera E
Rev Esp Med Nucl Imagen Mol; 2015; 34(3):155-61. PubMed ID: 25443648
[TBL] [Abstract][Full Text] [Related]
7. Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.
Lalire P; Zalzali M; Garbar C; Bruna-Muraille C; Morland D
Clin Nucl Med; 2016 Jun; 41(6):512-3. PubMed ID: 26914574
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
9. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
10. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
11. Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Fuccio C; Castellucci P; Schiavina R; Santi I; Allegri V; Pettinato V; Boschi S; Martorana G; Al-Nahhas A; Rubello D; Fanti S
Ann Nucl Med; 2010 Jul; 24(6):485-92. PubMed ID: 20544323
[TBL] [Abstract][Full Text] [Related]
12. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
[TBL] [Abstract][Full Text] [Related]
13. Needle track recurrence after transrectal prostate biopsy detected by ¹⁸F-Choline PET-CT.
Garcia-Bennett J; Henríquez I; Zugazaga Cortazar A; Fuertes J
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):128-9. PubMed ID: 25037682
[No Abstract] [Full Text] [Related]
14. Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan.
Su HY; Chen ML; Hsieh PJ; Hsieh TS; Chao IM
Clin Nucl Med; 2016 May; 41(5):392-3. PubMed ID: 26859201
[TBL] [Abstract][Full Text] [Related]
15. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
Kwee SA; Coel MN; Ly BH; Lim J
Ann Nucl Med; 2009 Aug; 23(6):541-8. PubMed ID: 19529978
[TBL] [Abstract][Full Text] [Related]
16. Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images.
Bagni O; Filippi L; Schillaci O
Clin Nucl Med; 2015 Jun; 40(6):e328-30. PubMed ID: 25674873
[TBL] [Abstract][Full Text] [Related]
17. The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Tabrizipour AI; Dunne M
Clin Nucl Med; 2015 May; 40(5):e285-6. PubMed ID: 25608148
[TBL] [Abstract][Full Text] [Related]
18. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
19. Colorectal carcinoma with bone metastases detected by 18F-choline PET/CT.
Treglia G; Ceriani L; Barizzi J; Paone G; Giovanella L
Clin Nucl Med; 2014 Mar; 39(3):e246-8. PubMed ID: 24458184
[TBL] [Abstract][Full Text] [Related]
20. Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
Bertagna F; Bertoli M; Treglia G; Manenti S; Salemme M; Giubbini R
Clin Nucl Med; 2014 Oct; 39(10):e442-4. PubMed ID: 24561683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
